BAM15
Also known as: BAM 15 · Mitochondrial Uncoupler BAM15
A selective mitochondrial uncoupler that increases energy expenditure by diverting the proton gradient from ATP synthesis to heat production. In mouse models, BAM15 reversed diet-induced obesity and insulin resistance without increasing body temperature, heart rate, or affecting the plasma membrane — overcoming the critical safety limitations of earlier uncouplers like DNP.
What is BAM15? A selective mitochondrial uncoupler that increases energy expenditure by diverting the proton gradient from ATP synthesis to heat production. In mouse models, BAM15 reversed diet-induced obesity and insulin resistance without increasing body temperature, heart rate, or affecting the plasma membrane — overcoming the critical safety limitations of earlier uncouplers like DNP.
How does BAM15 work? BAM15 is a protonophoric compound that selectively permeabilizes the inner mitochondrial membrane to protons, uncoupling the electron transport chain from ATP synthase. This forces mitochondria to burn more fuel (fat) to maintain the membrane potential, dramatically increasing metabolic rate. Crucially, its bulky structure prevents it from crossing the plasma membrane, making it organ-selective and avoiding the hyperthermia that makes DNP dangerous.
Benefits of BAM15: Reverses diet-induced obesity in mouse models; Increases resting metabolic rate without hyperthermia; Improves insulin sensitivity and glucose metabolism; Does not increase body temperature (unlike DNP); No effect on heart rate at therapeutic doses; Prevents mitochondrial membrane-selective uncoupling; May have anti-cancer metabolic effects
BAM15 dosage: Mouse studies used 5-20mg/kg. Human dose not established. Research compound only — significant caution warranted.
BAM15 half-life: Unknown
Research status: Research Only
Source: PeptideWiki — https://www.peptide-wiki.net/peptides/bam15
Mechanism of Action
BAM15 is a protonophoric compound that selectively permeabilizes the inner mitochondrial membrane to protons, uncoupling the electron transport chain from ATP synthase. This forces mitochondria to burn more fuel (fat) to maintain the membrane potential, dramatically increasing metabolic rate. Crucially, its bulky structure prevents it from crossing the plasma membrane, making it organ-selective and avoiding the hyperthermia that makes DNP dangerous.
Benefits
- Reverses diet-induced obesity in mouse models
- Increases resting metabolic rate without hyperthermia
- Improves insulin sensitivity and glucose metabolism
- Does not increase body temperature (unlike DNP)
- No effect on heart rate at therapeutic doses
- Prevents mitochondrial membrane-selective uncoupling
- May have anti-cancer metabolic effects
Side Effects & Risks
- Limited human data — primarily mouse models
- Theoretical hyperthermia risk at high doses
- GI discomfort possible
- Not cleared for human use
Where to Buy BAM15
3 options across 3 vendors · Sorted cheapest first · All include direct product link
From
$125.00
All links are affiliate links — PeptideWiki earns a commission at no extra cost to you. Coupon codes apply at checkout. Prices and availability may change. Always verify COA before purchasing.
Storage & Reconstitution Guide
Storage Temperature
-20°C (lyophilized)
24 months (lyophilized), 28 days (reconstituted)
Reconstitution Solvent
Bacteriostatic water (BAC water)
Swirl gently — do not shake or vortex
Handling Notes
Protect lyophilized peptide from moisture and light. Once reconstituted, keep refrigerated. Discard if solution becomes cloudy or discolored. Use insulin syringe for precise dosing.
Step-by-Step Reconstitution
Gather supplies
BAC water, insulin syringe, alcohol swabs, vial
Disinfect tops
Swab rubber stoppers of both vials with alcohol
Draw BAC water
Pull desired mL of BAC water into syringe
Inject slowly
Inject BAC water down the side of the peptide vial, swirl gently to dissolve
Preclinical Research & Reviews1
BAM15-mediated mitochondrial uncoupling protects against obesity without hyperthermia
BAM15 prevented and reversed diet-induced obesity in mice without increasing body temperature or heart rate — overcoming the key safety limitations of earlier mitochondrial uncouplers like DNP.
Result
Prevented and reversed diet-induced obesity
Safety
No hyperthermia, no heart rate increase, plasma membrane sparing
Mechanism
Selective inner mitochondrial membrane proton transport
Research Protocol
- Dose Range
- 5–20 mg/kg/kg
- Frequency
- Once daily oral
- Cycle
- 4-8 weeks
- Half-Life
- Unknown
- Routes
- oral
- Notes
- Mouse studies used 5-20mg/kg. Human dose not established. Research compound only — significant caution warranted.
Legal & Regulatory Status
Sold for research purposes only. Not for human use. Laws vary by country.
Commonly Stacked With
View all peptide stacks →External Resources
Chemical Properties
- CAS Number
- 1429651-50-2
- Mol. Weight
- 357.4 Da
- Formula
- C13H10F3N3O4S
PeptideWiki Research Team
Evidence-based research data sourced from PubMed and ClinicalTrials.gov · Last updated: February 25, 2026
Frequently Asked Questions About BAM15
What is BAM15?▾
A selective mitochondrial uncoupler that increases energy expenditure by diverting the proton gradient from ATP synthesis to heat production. In mouse models, BAM15 reversed diet-induced obesity and insulin resistance without increasing body temperature, heart rate, or affecting the plasma membrane — overcoming the critical safety limitations of earlier uncouplers like DNP.
What are the benefits of BAM15?▾
Reverses diet-induced obesity in mouse models
What are the benefits of BAM15?▾
Increases resting metabolic rate without hyperthermia
What are the side effects of BAM15?▾
Limited human data — primarily mouse models
What is the recommended dosage for BAM15?▾
Mouse studies used 5-20mg/kg. Human dose not established. Research compound only — significant caution warranted.
How long should a BAM15 cycle last?▾
4-8 weeks
More Weight Management Peptides
View all Weight Management peptides →5-Amino-1MQ
5-Amino-1-methylquinolinium
A small molecule inhibitor of NNMT enzyme that boosts metabolism and promotes fat cell apoptosis. Shows promise as a novel anti-obesity agent in preclinical research.
Retatrutide
LY3437943
An emerging triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 3 clinical trials show unprecedented weight loss of up to 24% body weight.
AOD-9604
AOD9604
A synthetic fragment of the C-terminus of HGH (amino acids 176-191) that retains the fat-burning properties of growth hormone without affecting blood sugar or IGF-1 levels.
MOTS-C
Mitochondrial Open Reading Frame of the 12S rRNA-c
A mitochondria-derived peptide that acts as a metabolic regulator, improving insulin sensitivity, exercise capacity, and potentially mimicking caloric restriction.